About Us Portfolio Press Careers Sitemap Advertise Contact Us Make this your Homepage

Custom Search

Register

Sign In

Sign In Using Facebook

Home » Corporate News

Bayer Confirms European Approval for Endometriosis Drug

by Rajshri on December 08, 2009 at 3:03 PM Corporate News

European approval for Visanne, a drug which treats the gynecological disease endometriosis has been obtained, according to German pharmaceutical and chemical group Bayer.

Bayer Confirms European Approval for Endometriosis Drug

Related Links

In the United States meanwhile, Bayer is still waiting for a green light for Rivaroxaban, a blood thinning treatment.

Bayer said Visanne would go on sale in Europe in the second quarter of 2010, and will provide relief from pain associated with lesions and inflammation outside the uterus.

The company said the condition affects around five to 10 percent of women of childbearing age.

"Lower abdominal and pelvic pain, cramping menstrual pains (dysmenorrhea), painful sexual intercourse (dyspareunia) and infertility are well recognized symptoms of endometriosis," a statement said.

On Sunday however, Bayer said regulatory approval of Rivaroxaban in the United States had not been completed, and that the company would not be able to provide the US Food and Drug Administration (FDA) with additional information as requested, by the end of the year.

Rivaroxaban has been used in tests to treat thrombosis or blood clots following hip and knee operations.

Bayer originally sought FDA approval for the drug in July 2008, but US authorities have requested more information on it.

Sold under the dame Xarelto in Europe, the drug is one of Bayer's best hopes for for its health-care division, along with the cancer treatement Nexavar.

Shares in Bayer lost 2.01 percent to 52.65 euros in early Frankfurt trading on the news, while the DAX index of leading German stocks was 0.97 percent lower overall.

Source-AFP
RAS

Study Links Chromosome Changes to Cancer

Help N.Korea on Swine Flu, S.Korea Leader Urges

More News on: Drug Toxicity, Hormone Replacement Therapy, Pelvic Pain in Women, Endometriosis, Primary Amenorrhea , Signature Drug Toxicity

Comment & Contribute

Comments should be on the topic and should not be abusive. Comments are normally moderated and are reviewed after they are posted.
* Your comment can be maximum of 2500 characters
	Notify me when reply is posted I agree to the terms and conditions
Your comments are automatically posted once they are submitted. All comments are however constantly reviewed for spam and irrelevant material (such as product or personal advertisements, email addresses, telephone numbers and website address). Such insertions do not conform to our policy and 'Terms of Use' and are either deleted or edited and republished. Please keep your comments brief and relevant.This section may also have questions seeking help. If you have the information you are welcome to respond, but please ensure that the information so provided is genuine and not misleading.

DrParveen(Guest)

09/02/2011

When vissane will come in the market and what is the role in treating endometreosis ?

Reply | Forward

depti(Guest)

08/27/2010

when will these drugs be avalable .how much efective they can be?

Reply | Forward

Medwonders Health Network

Support Groups Members Discussions

Total Members - 55031
Support Groups - 445

Health News Index

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Latest News Most Popular Most Commented

Access to Kidney Transplantation and Racial Disparities

Increasing Obesity and Diabetes Contribute to Drug Eluting Balloons Market Growth

Mobile Awareness and Screening for Kidney Disease Launched in Chennai

Breastfed Babies Less Likely to Become Angry: Study

Study Says 7-hour Sleep Helps High School Students Do Better

News Archive
Date :
Category :
Keyword :

News Quick Links

	News Central			Health Watch
	Latest Health News			Health In Focus
	News Category (500+)			Breaking Health News
	Popular News			Celebrating Life
	Health News and Press Release			Medindia - Exclusive
	News Photo Gallery			India Special
	News Video Gallery			Lifestyle and Wellness
	News From Other Resources

Endometriosis

Complete Medindia Resources

News Categories:


»	Research Says Annual Cost of Defensive Orthopedic Medicine is $2 Billion

»	RSBY to Provide Health Insurance for 66,000 J&K Families

»	Same-sex Couples in US can Now Access Health Insurance

»	Bill on Insurance Premium for Farmers Approved by Poland Cabinet

»	Co-contribution On The Rise For Group Insurance
More Insurance News

Corporate Related News
»	Pfizer Initiates Recall of Birth Control Pills in the US	»	J&J Initiates Voluntary Recall of Aveeno Baby Lotion
»	Fortis to Launch Chain of Dialysis Centers to Broaden Access to Quality Care	»	Pacific Edge Buoyed by European Acceptance of Gastric Cancer Detection Patents
»	FDA Approves Abbott�s Xience Prime Coronary Stent	»	Circadian Technologies� Investigative Cancer Drug Receives FDA Nod for Clinical Trials
»	CooperVision Issues Another Statement Over Contact Lens Recall	»	Conditional Nod for Proposed Teva Buy

Read More >>

Bayer Confirms European Approval for Endometriosis Drug

Medwonders Health Network

Corporate Related News

Consumers

Medical Professionals

Medical Students

Directories